#3748
Association of MINEN with GIST on neurofibromatosis – A case report
Introduction:
Although most digestive neuroendocrine tumors (NETs) are sporadic, around 5% of NETs occur in a context of hereditary predisposition, mainly type 1 multiple endocrine neoplasia (NEM1) and Von Hippel-Lindau disease (VHL).
Conference:
Presenting Author:
Authors:
Samia K,
Fatima H,
Nabil B,
Benali T,
Aisha B,
Keywords:
NEN,
GIST,
MINEN,
DOG1,
#2815
Unexpected High Rate of Metastases in Type 1 Gastric Neuroendocrine Neoplasia
Introduction:
Gastric neuroendocrine neoplasms (gNEN) represent about 7.5% of gastroenteropancreatic NEN (gepNEN), classified in: type 1 (70-80%), related to autoimmune gastritis, type 2 (5%), related to Zollinger-Ellison syndrome in multiple endocrine neoplasia 1 and type 3 (15-20%), in absence of hypergastrinemia or mucosal atrophy.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
Bottiglieri F,
Modica R,
de Cicco F,
Minotta R,
Faggiano A,
Keywords:
gastric,
neuroendocrine,
type1,
type3,
metastases,
#844
Variation Between Chromogranin A Assays in the Diagnosis of Gastric Carcinoid Type 1
Introduction:
Chromogranin A (CgA) is not very accurate for the diagnosis of gastric carcinoid type1 (GC1). Clinical interpretation of CgA results may be affected by the heterogeneity between CgA assays. The commercial CgA assay, DAKO (DAKO, Denmark A/S, Glostrup, Denmark) is an ELISA which recognizes a 23 kD C terminal fragment of CgA; the Imperial Supra-regional Assay Service radioimmunoassay (SAS Hammersmith Hospital, Imperial College, London) is a competitive radioimmunoassay raised against the whole pancreastatin molecule.
Conference:
11th Annual ENETSConcerence (2014)
Presenting Author:
Authors:
Rossi R,
Martin N,
Garcia-Hernandez J,
Mandair D,
Mohmaduves M,
Keywords:
gastric carcinoid type 1,
chromogranin A,
